Drug interactions
Gliclazide + Mecasermin
Severity: Major
Gliclazide and Mecasermin: major interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Mecasermin is recombinant IGF-1 and itself causes hypoglycemia. Combined with a sulfonylurea, the glucose-lowering effect is additive and severe hypoglycemia may occur.
What this interaction means in plain words
Gliclazide and Mecasermin can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Gliclazide belongs to Endocrine; Mecasermin belongs to Endocrine.
Why it happens
Additive pharmacodynamic hypoglycemic effects, as IGF-1 has insulin-like activity and gliclazide stimulates insulin secretion.
What to do
Monitor blood glucose closely and consider reducing the gliclazide dose. Give mecasermin with or shortly after a meal and teach the patient to recognize and treat hypoglycemia.
What to ask your pharmacist
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Gliclazide and Mecasermin, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Gliclazide
Other interactions of Mecasermin
Frequently asked questions
Can I take Gliclazide with Mecasermin?
MediHelp rates the interaction as major. Gliclazide and Mecasermin can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Mecasermin is recombinant IGF-1 and itself causes hypoglycemia. Combined with a sulfonylurea, the glucose-lowering effect is additive and severe hypoglycemia may occur.
How serious is the interaction between Gliclazide and Mecasermin?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose closely and consider reducing the gliclazide dose. Give mecasermin with or shortly after a meal and teach the patient to recognize and treat hypoglycemia.
What other medicines interact with Gliclazide?
MediHelp also lists interactions of Gliclazide with, for example, Ciprofloxacin, Clarithromycin, Disopyramide. The full list is on the Gliclazide page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
